Principal Financial Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,771
| Closed | -$365K | – | 2528 |
|
|
2020
Q4 | $365K | Sell |
2,771
-5,130
| -65% | -$676K | ﹤0.01% | 2197 |
|
|
2020
Q3 | $399K | Sell |
7,901
-106
| -1% | -$5.35K | ﹤0.01% | 2062 |
|
|
2020
Q2 | $382K | Buy |
8,007
+2,413
| +43% | +$115K | ﹤0.01% | 2036 |
|
|
2020
Q1 | $274K | Buy |
5,594
+181
| +3% | +$8.87K | ﹤0.01% | 1983 |
|
|
2019
Q4 | $311K | Buy |
+5,413
| New | +$311K | ﹤0.01% | 2048 |
|